Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:957-964
Published online before print October 9, 2003, doi: 10.1161/01.RES.0000099883.68414.61
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/10/957    most recent
01.RES.0000099883.68414.61v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurney, A.M.
Right arrow Articles by Kempsill, F.E.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurney, A.M.
Right arrow Articles by Kempsill, F.E.J.
Related Collections
Right arrow Functional genomics
Right arrow Ion channels/membrane transport
Right arrow Pulmonary circulation and disease
(Circulation Research. 2003;93:957.)
© 2003 American Heart Association, Inc.


Cellular Biology

Two-Pore Domain K Channel, TASK-1, in Pulmonary Artery Smooth Muscle Cells

A.M. Gurney, O.N. Osipenko, D. MacMillan, K.M. McFarlane, R.J. Tate, F.E.J. Kempsill

From the Department of Physiology and Pharmacology (A.M.G., R.J.T.), University of Strathclyde, Glasgow, UK; Quintiles Scotland Ltd (O.N.O., K.M.M.), Heriot-Watt University Research Park, Edinburgh, UK; Institute of Biomedical and Life Sciences (D.M.), University of Glasgow, Glasgow, UK; Argyll and Clyde NHS (F.E.J.K.), Royal Alexandra Hospital, Paisley, UK.

Correspondence to Prof Alison M. Gurney, Department of Physiology and Pharmacology, University of Strathclyde, 27 Taylor St, Glasgow, UK G4 0NR. E-mail a.m.gurney{at}strath.ac.uk


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Pulmonary vascular tone is strongly influenced by the resting membrane potential of smooth muscle cells, depolarization promoting Ca2+ influx, and contraction. The resting potential is determined largely by the activity of K+-selective ion channels, the molecular nature of which has been debated for some time. In this study, we provide strong evidence that the two-pore domain K+ channel, TASK-1, mediates a noninactivating, background K+ current (IKN), which sets the resting membrane potential in rabbit pulmonary artery smooth muscle cells (PASMCs). TASK-1 mRNA was found to be present in PASMCs, and the membranes of PASMCs contained TASK-1 protein. Both IKN and the resting potential were found to be exquisitely sensitive to extracellular pH, acidosis inhibiting the current and causing depolarization. Moreover, IKN and the resting potential were enhanced by halothane (1 mmol/L), inhibited by Zn2+ (100 to 200 µmol/L) and anandamide (10 µmol/L), but insensitive to cytoplasmic Ca2+. These properties are all diagnostic of TASK-1 channels and add to previously identified features of IKN that are shared with TASK-1, such as inhibition by hypoxia, low sensitivity to 4-aminopyridine and quinine and insensitivity to tetraethylammonium ions. It is therefore concluded that TASK-1 channels are major contributors to the resting potential in pulmonary artery smooth muscle. They are likely to play an important role in mediating pulmonary vascular responses to changes in extracellular pH, and they could be responsible for the modulatory effects of pH on hypoxic pulmonary vasoconstriction.


Key Words: two-pore domain K channel • pulmonary artery myocyte • smooth muscle • resting potential


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The membrane potential of pulmonary artery smooth muscle cells (PASMCs) is an important factor in the control of pulmonary vascular tone. This is reflected in the vasoconstrictor effect of agents causing membrane depolarization1–3 and the vasodilator action of drugs causing hyperpolarization.4,5 There is general agreement that the resting potential of PASMCs is determined largely by a noninactivating K+ conductance (IKN) that is sensitive to inhibition by 4-aminopyridine, albeit at relatively high (>1 mmol/L) concentrations.6 Thus, both the resting potential and IKN are abolished when pipette K+ is replaced with equimolar Cs+, whereas equimolar substitution of Cs+ for extracellular K+ has little effect.7 In addition, both the resting potential and IKN display low sensitivity to the drugs quinine and Ba2+ and are insensitive to tetraethylammonium ions, glibenclamide, and a range of Ca2+-activated K+-channel blockers.7,8 This pharmacological profile is reminiscent of the two-pore domain K+ channel, TASK-1, which was recently shown to act as a background K+ conductance regulating resting potential in neuronal,9–11 cardiac,12 and adrenal glomerulosa13 cells. Because an important characteristic of the resting conductance in PASMCs is that it is inhibited by hypoxia, leading to membrane depolarization and Ca2+ influx,3,7,14–16 we were especially interested in the finding that hypoxia inhibits recombinant TASK-1 channels.17 Moreover, channels with TASK-like properties have been found to underlie oxygen-sensing K+ currents in chemosensitive cells of the carotid body, airways, and central nervous system.18–20 This raises the possibility that TASK-1 channels might be the molecular correlate of IKN and be responsible for setting the resting membrane potential in PASMCs. Indeed, mammalian lung has been shown to express mRNA for TASK-1,21 although it is unclear in which of the many cell types present in lung it is located.

A defining characteristic of TASK-1 channels is their high sensitivity to changes in extracellular pH.22 Although specific and selective inhibitors of TASK-1 channels have yet to be identified, the channels do display a distinctive pharmacological profile. Thus, in addition to the drug sensitivities described above, TASK-1 channels are characteristically activated by volatile anesthetics like halothane23 and inhibited by low concentrations of anandamide24 and Zn2+.25 These properties were exploited in the present study to investigate the expression of TASK-1 channels in rabbit PASMCs and their contribution to the background K+ current, IKN, and the resting membrane potential. The results provide the first demonstration of an important functional role for a two-pore domain K+ channel in vascular smooth muscle.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
New Zealand White rabbits (2 to 3 kg; Harlan UK Ltd, Bicester, UK) were euthanized by sodium pentobarbitone overdose (80 mg/kg IV), according to the UK Animals (Scientific Procedures) Act, 1986. The main pulmonary artery and its right and left branches were dissected free and placed in physiological salt solution (PSS) of the following composition (in mmol/L): NaCl 124, KCl 5, CaCl2 1.8, MgCl2 1, NaH2PO4 0.5, KH2PO4 0.5, glucose 10, 5-N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) 15; adjusted to pH 7.3 with NaOH. Smooth muscle cells were dissociated by overnight incubation with papain as previously described,26 or by incubating 1-mm strips of artery for 30 minutes at 37°C with 12 mg collagenase (Sigma type 1A), 1 mg protease (Sigma type XXIV), 10 mg trypsin inhibitor (Sigma), and 10 mg bovine serum albumin (BSA) in 5 mL dissociation medium (DM) of the following composition (in mmol/L): NaCl 110, KCl 5, NaHCO3 15, CaCl2 0.16, MgCl2 2, NaH2PO4 0.5, KH2PO4 0.5, glucose 10, HEPES 15, phenol red 0.04, ethylenediaminetetraacetic acid (EDTA) 0.49, taurine 10; adjusted to pH 7.0 with NaOH. Resting potential and IKN amplitude were not significantly different in cells obtained with either method.

Reverse transcription (RT) PCR was preformed on total RNA extracted from suspensions of rabbit PASMCs as previously described27 or single PASMCs harvested under microscope control and aspirated directly into the RT-PCR mix. Four sets of primer pairs (PP) were designed against conserved sequences in mouse (GenBank accession No. AB013345), rat (AB048823), and human (NM_002246) TASK-1 channels. They were as follows: PP1, 5'-TCCATGTGCTCGTGCCTCTG-3', 5'-AGCTCCTGCGCTT-CATGAGG-3'; PP2, 5'-GGCAAGGTGTTCTGCATGTTCTACG-3', 5'-AAGCCGATGGTGGTGAGGGTG-3'; PP3, 5'-CCTTCTACTT-CGCCATCACCGTCATC-3', 5'-CATGTTGGCCATGGACACCTCG-3'; PP4, 5'-TCATCGTGTGCACCTTCACCTACCTG-3', 5'-CATGTT-GGCCATGGACACCTCG-3'. PP2, PP3, and PP4 target overlapping regions of the TASK-1 template (see Figure 1C). Cycle parameters were typically 95°C for 5 minutes, followed by 20 to 35 cycles at 95°C for 1 minute, 52°C to 56°C for 30 seconds, and 68°C for 2 to 4 minutes. Reverse transcriptase was omitted from control cDNA reactions. Products were resolved by agarose gel electrophoresis, purified, and verified by sequencing.



View larger version (60K):
[in this window]
[in a new window]
 
Figure 1. RT-PCR products visualized with ethidium bromide. A, Four different primer pairs (PP1 through PP4 as indicated) amplified products of the predicted size from PASMC suspensions. Each column represents a separate reaction with (+) or without (-) reverse transcriptase. B, Single-cell RT-PCR applied to PASMCs using primer pair PP3. Each lane represents a single cell. M indicates size markers; arrows indicate 400 bp. C, DNA sequence of mouse TASK-1 with the regions amplified by the primer pairs used in A and B underlined. Labels indicate the lines on which each region starts, with the predicted size of the amplicons in parentheses.

Immunofluorescence was performed as previously described,27 using two different antibodies directed against unique domains in TASK-1, one at the amino terminus (Santa Cruz Biotechnology) and the other at residues 252 to 269 in the carboxy terminal end of the protein (Alomone Labs). Cells adhered to glass coverslips were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) for 10 minutes then permeabilized with 0.1% Triton X-100 in PBS for 5 minutes. After blocking with 1% BSA for 1 hour, cells were incubated with anti-TASK-1 antibody (1:100 dilution) for 1 hour then probed for 1 hour with a secondary antibody conjugated to fluorescent Alexa 488, or a biotinylated secondary antibody followed by streptavidin-Alexa 488. Duplicates were processed without primary antibody for controls. Fluorescence was imaged at wavelengths >500 nm with a BioRad Radiance 2000MP confocal microscope, using the 488-nm line of an argon laser and a Nikon x60 (N.A. 1.0) objective.

For electrophysiological experiments, cells were superfused at {approx}0.5 mL/min at room temperature with PSS supplemented with 10 mmol/L tetraethylammonium chloride (TEA) and 10 µmol/L glibenclamide to block BKCa and KATP channels, respectively. The whole-cell patch-clamp technique was used as previously described to measure the resting membrane potential under current clamp and macroscopic K+ currents under voltage clamp.8 Unless otherwise indicated, pipettes were filled with the following: (in mmol/L) KCl 130, MgCl2 1, ethyleneglycol bis(ß-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) 1, HEPES 20, Na2GTP 0.5; pH adjusted to 7.2 with KOH. Where indicated, 10 mmol/L 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) was substituted for EGTA. Pipette resistance was 2 to 4 M{Omega}. To isolate IKN from other voltage-dependent K+ currents, cells were clamped at 0 mV for at least 5 minutes. To suppress Cl- currents in some experiments, all but 10 mmol/L of the Cl- in both the PSS and pipette solution was replaced with methanesulphonate. Currents were filtered at 0.5 to 5 kHz and digitized at 0.62 to 20 kHz and were not leak subtracted. Current amplitudes were normalized against cell capacitance, measured from the current response to -5 or -10 mV steps applied from a -80 mV holding potential. Drugs were applied from a manually operated, gravity fed, multibarrel perfusion pipette positioned close to the cell, which changed the solution around the cell in a few seconds.

The pH of the PSS was set with 1 mol/L NaOH. The order of the change in pH was randomized for each experiment and had no effect on the results. Halothane was dissolved in dimethylsulphoxide (DMSO) to 1 mmol/L, diluted in PSS, and used immediately. Other drug solutions were prepared from frozen aliquots. Glibenclamide (10 mmol/L) was dissolved in DMSO and anandamide (10 mmol/L) in 50% ethanol in water. Effects of these drugs were determined by comparison with vehicle controls. Other drugs were dissolved in deionized water. Data are expressed as mean±SEM of n cells. Statistical comparisons used one-way analysis of variance (ANOVA), with probability values corrected by Tukey’s pairwise comparison, or Student’s paired or unpaired t test as appropriate. A value of P<0.05 was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Expression of TASK-1 Channels in PASMCs
We first established the presence of TASK-1 mRNA in rabbit PASMCs. RT-PCR experiments with four specific primer pairs for TASK-1 indicated that mRNA for the channel is present in suspensions of cells isolated from pulmonary arteries (Figure 1A). These results were reproduced in separate RT-PCR reactions on RNA from at least three rabbits. Although the suspensions contained predominantly smooth muscle cells, they were almost certainly contaminated with endothelial and other cells. To verify the smooth muscle origin of the amplified mRNA, further RT-PCR experiments were performed on single, identified PASMCs. Figure 1B shows reproducible amplification of a PCR product of the predicted size from a single PASMC, using primer pair PP3. Immunocytochemistry provided further evidence for TASK-1 expression in PASMCs. The presence of TASK-1 protein was established with two anti-TASK-1 antibodies directed against either the amino or carboxy terminal regions of the protein. Both antibodies resulted in fluorescent labeling in PASMCs from at least six separate preparations (Figures 2A and 2B). In contrast, staining was absent from control cells treated in the same way, but without exposure to TASK-1 antibody (Figures 2C and 2D). Confocal microscopy of cells stained with both antibodies showed the presence of TASK-1 staining at the surface membrane and in the cytoplasm.



View larger version (61K):
[in this window]
[in a new window]
 
Figure 2. Fluorescence images of PASMCs stained with the Alomone C-terminal TASK-1 antibody (A) or Santa Cruz N-terminal antibody (B). Staining is absent in control cells treated in the same way but without exposure to primary antibody, as shown by matched fluorescence (C) and transmitted light (D) images of control cells taken under identical conditions.

K+ Current Modulation by pH
A defining hallmark of the TASK family of channels is their sensitivity to extracellular pH (pHo). As shown in Figure 3A, varying the pH of the extracellular solution caused reversible changes in the resting membrane potential of isolated rabbit pulmonary artery myocytes. The relationship between resting potential and pHo is illustrated in Figure 3B, where the resting potentials measured at pH 6.3, 7.3, and 8.3 were significantly different (P<0.001, ANOVA). Increasing pHo from 7.3 to 8.3 caused membrane hyperpolarization of 8±2 mV (n=8), whereas acidification to pH 6.3 depolarized cells by 20±5 mV (n=5). These changes in membrane potential were reflected in the effects of pHo on the amplitude of the noninactivating K+ current, IKN, recorded at 0 mV (Figure 3C). In 10 cells, the mean amplitude of the current measured at pH 6.3 was 48±7% of that measured at pH 7.3, whereas the current at pH 8.3 was 163±14% of that at pH 7.3. The modulation of IKN and resting potential by pHo was usually apparent within seconds of changing the perfusion solution, consistent with a direct effect of pHo on the channels rather than mediation by slow changes in intracellular pH. Figure 3D illustrates the effect of pHo across the full voltage range over which IKN is resolved. From the holding potential of 0 mV, the voltage was stepped to 60 mV and then ramped to -10 mV over a period of 1 second. The current during the ramp reflects IKN in parallel with a nonspecific "leak" current and reverses direction at the resting potential of the cell.8 The effect of pHo was restricted to membrane potentials of -60 mV or above, where IKN is active. It had little effect at more negative potentials where leak current predominates. As a consequence of modulating outward current, pHo also influenced the reversal potential of the current recorded during voltage ramps. Consistent with the depolarizing effect of acidification, a positive shift of 5±2 mV (n=3) resulted when pHo was reduced from 7.3 to 6.8, whereas increasing pHo to 7.8 caused a shift of -9±3 mV (n=3). Figure 3E shows the pHo dependence of IKN measured at 0 mV. Fitting a Boltzmann relationship to the data indicates that the pHo giving 50% inhibition (pH0.5) was pH 7.3.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 3. Modulation of membrane potential and IKN by pH. A, Increasing the extracellular pH (pHo) from 7.3 to 8.3 hyperpolarized the cell membrane while reducing the pH to 6.3 caused depolarization. B, Histogram showing mean resting membrane potential ±SEM at different pHo. P=0.00001 by ANOVA. C, Membrane current recorded at 0 mV when the PSS was buffered at pH 7.3, following acidification to pH 6.3 and after increasing pHo to 8.3. D, Records of IKN at different pHo, during 1-second voltage ramps from 60 to -100 mV applied from a holding potential of 0 mV. E, Relationship between pHo and IKN measured at 0 mV. Data were fit with a Boltzmann relationship with pH0.5=7.3.

Varying the extracellular pH also modulated IKV, the K+ current activated during short (250 ms) depolarizing steps applied from a holding potential of -80 mV. This is illustrated in Figure 4A where the main effect appears to be on current inactivation, which was accelerated by acidification and slowed by alkalinization. Thus, at pH 8.3, the peak amplitude of IKV at 40 mV, seen as an early transient component that has been likened to A-current,26 was unchanged compared with that at pH 7.3 (106±12%, n=3). In contrast, the sustained component of current measured at 200 ms in the same cells, attributed to delayed rectifier channels,26 was significantly enhanced at pH 8.3 compared with pH 7.3 (147±12%, n=3, P<0.05). Reducing the pH from 7.3 to 6.3 suppressed both components of current, although inhibition of the sustained component (56±13%, n=3, P<0.01) was usually more pronounced than the early peak current (42±12%, n=3, P<0.05). As shown in Figure 4B, the effect of pHo on the sustained IKV appeared within a few seconds of changing the solution and was fully reversible. Modulation was apparent across the voltage range over which IKV was activated, with similar percentage changes measured at all potentials (Figure 4C). It is clear from Figure 4C that acidification reduced the current at -40 mV, implying that inhibition of IKV could have contributed to its depolarizing effect.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Sensitivity of IKV to pHo. A, Records of IKV activated by 240-ms steps to 40 mV from a holding potential of -80 mV, obtained at pHo 6.3, 7.3, and 8.3. B, Time course of the changes in amplitude of the sustained current when pHo was increased from 7.3 to 8.3 then decreased to 6.3. Currents were activated at 15-second intervals and the amplitude measured as the average current during the last 10 ms of the test pulse. C, Effect of pHo on the current versus voltage relationship for the sustained current; voltage protocol inset. *P<0.05, **P<0.01, ***P<0.001 by ANOVA.

Modulation by Halothane, Anandamide, and Zn2+
Another marker of TASK channels is their sensitivity to volatile anesthetics, such as halothane, which cause facilitation of channel activity. As illustrated in Figure 5A, 1 mmol/L halothane caused facilitation of the noninactivating current at 0 mV in 12 out of 14 cells. The mean facilitation observed was 19±4% (n=14), halothane significantly increasing IKN at 0 mV from 15±3 to 18±4 pA (n=14, P<0.01). This effect was fully reversible, although it sometimes took a few minutes for the current to return to the control level after washout. Consistent with the involvement of TASK-1 channels in this facilitation,28 it was blocked at acid pHo (Figure 5B). Thus, when cells were bathed in PSS at pH 6.3, the mean current was 4±3 pA before and 3±3 pA (n=9) after applying halothane (1 mmol/L). The stimulatory effect of halothane was restricted to potentials positive of -60 mV, with no effect on the leak current at more negative potentials (Figure 5C). In five of the cells studied at pH 7.3, the facilitation caused by halothane was transient. Thus in the continuous presence of halothane, the response in these cells appeared biphasic, and in some the current eventually declined to below the control level (not shown). This may reflect an additional inhibitory effect of halothane, because a small inhibition was observed in the two cells that failed to show facilitation in response to halothane. The mean reduction in current amplitude amounted to 16±6% of the maximum (facilitated) current (n=7). The inhibitory effect became more pronounced at higher halothane concentrations. Thus at 2 or 5 mmol/L halothane, facilitation was observed in only three of eight cells and inhibition, amounting to a decrease in the current amplitude of 37±9% (n=8), was predominant. The effects of halothane on the resting membrane potential mirrored its effects on IKN. Thus, 1 mmol/L halothane caused a small but significant hyperpolarization (Figure 5D) of -2.7±0.7 mV (n=7, P<0.01), whereas at higher halothane concentrations (2 to 5 mmol/L), depolarization from -42±1 to -34±5 mV (n=3) was predominant. A biphasic effect was observed in some cells. In contrast to its effects on IKN, up to 5 mmol/L halothane had no consistent effect on the amplitude of the transient or sustained IKV, measured over a range of test potentials (Figure 5E).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 5. Effects of halothane on resting potential and K+ currents. A, Facilitation of the noninactivating current recorded at 0 mV when halothane (1 mmol/L) was applied at pH 7.3. B, When applied at pH 6.3, halothane (1 mmol/L) did not facilitate the current. C, IKN during voltage ramps (protocol inset) before and during facilitation induced by halothane (5 mmol/L). D, Effect of halothane (1 mmol/L) on resting potential (same cell as A). E, Current versus voltage relationship for sustained IKV before and after applying halothane (5 mmol/L; n=3); voltage protocol inset.

Although the effects of pH and the facilitatory action of halothane on membrane potential and IKN are indicative of a possible role for TASK channels, these agents discriminate poorly among different members of the TASK family and even other K channels. One agent that is able to inhibit TASK-1 at concentrations well below those affecting other TASK channels is Zn2+.25,29 As illustrated in Figure 6A, IKN recorded at 0 mV was reversibly inhibited by Zn2+ at relatively low concentrations in 11 out of 13 cells tested. At 100 µmol/L, Zn2+ reduced the current by 32±11% (n=6; P<0.05) and at 200 µmol/L inhibition increased to 53±10% (n=6; P<0.05). This effect of Zn2+ was restricted to membrane potentials above -60 mV, where IKN is active (Figure 6B). As shown in Figure 6C, the inhibition of IKN was associated with 10 mV depolarization of the resting potential from -37±4 mV to -27±6 mV (n=3). Unfortunately, the effect of Zn2+ was not selective, because as illustrated in Figure 6D (inset), it also inhibited the transient component of IKV, effectively slowing the rate of activation of KV current. Except at steps to -20 mV, Zn2+ (200 µmol/L) did not, however, alter the sustained component of IKV (Figure 6C).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 6. Zn2+ and anandamide inhibit IKN and membrane potential. A, Effect of 100 µmol/L Zn2+ on the noninactivating current recorded at 0 mV. B, Records of IKN in control conditions and in the presence of 200 µmol/L Zn2+. Current was markedly depressed at potentials above -60 mV, but not at more negative potentials. C, Effect of 200 µmol/L Zn2+ on the resting potential. D, Relationship between test potential and sustained IKV, activated by 250-ms depolarizing steps from a holding potential of -80 mV (protocol inset right), before and after applying 200 µmol/L Zn2+. Zn2+ had little effect on the sustained component, but suppressed the transient component of IKV (inset top). *P<0.05. E, Inhibition of IKN at 0 mV by 10 µmol/L anandamide.

The endocannabinoid anandamide was recently shown to be a direct and selective blocker of TASK-1 channels, low micromolar concentrations inhibiting these channels but not other TASK or two-pore domain channels.24 Figure 6E shows the effect of 10 µmol/L anandamide on the noninactivating current recorded at 0 mV. At this concentration, anandamide reduced IKN on average by 25±3% (n=8) from 13±4 to 10±3 pA (P<0.05), although in two cells it had no measurable effect.

IKN Lacks Sensitivity to Cytoplasmic Ca2+
Studies on recombinant TASK-1 channels have shown that intracellular Ca2+ has no effect on their activity,22 yet there is evidence that Ca2+ inhibits the resting K+ conductance in dog PASMCs.30 To test whether or not IKN in rabbit is a Ca2+-sensitive conductance, we first studied the effect on the current of increasing Ca2+ influx with the Ca2+ ionophore, A23187. This often induced inward current at negative potentials and increased outward current at positive potentials, probably due to the activation of Cl- channels by the rise in submembrane [Ca2+].31 To avoid this and its potential interference with IKN, the experiments were repeated using low Cl- (10 mmol/L) PSS and pipette solutions and measurements were confined to 0 mV, the Cl- equilibrium potential. At a concentration evoking contraction of rabbit PASMCs, A23187 (1 µmol/L) had no clear effect on the amplitude of IKN measured at 0 mV in these conditions (Figure 7A, n=3). In three other cells studied in normal recording solutions, the removal of extracellular Ca2+ also failed to change the amplitude of IKN at 0 mV (Figure 7B). This was despite the presence of 1 mmol/L EGTA in the bath solution to ensure that extracellular Ca2+ was buffered to a minimal level. An alternative method used to modulate the intracellular Ca2+ concentration was to vary the nature and concentration of the Ca2+ chelator used in the internal, pipette solution. The amplitude of IKN measured at 0 mV was not found to differ significantly when the pipette contained 0.05 to 0.1, 1 or 5 mmol/L EGTA, or 10 mmol/L BAPTA (Figure 7C).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 7. IKN lacks sensitivity to cytoplasmic Ca2+. A, IKN measured at 0 mV before and during application of the Ca2+ ionophore A23187 (1 µmol/L). B, IKN measured at 0 mV in PSS and after exposing the cell to Ca2+-free PSS. C, Mean amplitude of IKN (±SEM) measured at 0 mV when the pipette solution contained 50 or 100 µmol/L EGTA (n=21), 1 mmol/L EGTA (n=10), 5 mmol/L EGTA (n=11), or 10 mmol/L BAPTA (n=10). Amplitudes are not significantly different.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
We have demonstrated that the noninactivating K+ current, IKN, previously shown to underlie the resting potential of rabbit PASMCs,7 has all the properties expected for a background K+ channel belonging to the TASK family of two-pore domain channels. Pharmacological characterization previously demonstrated that IKN is insensitive to block by TEA, glibenclamide, Cs+, and a range of KCa channel blockers and is inhibited only at high concentrations of 4-aminopyridine and quinine.7,8 The present study shows that IKN is additionally sensitive to pHo, halothane, Zn2+, and anandamide, but not to intracellular Ca2+. Thus, the pharmacological profile of IKN and the resting potential of PASMCs closely matches that of heterologously expressed TASK-1 channels.21,32 The pHo at which 50% of IKN was inhibited, pH 7.3, is the same as that found for TASK-1 channels.22 Furthermore, the high sensitivity of IKN to inhibition by Zn2+ and anandamide strongly implicates TASK-1 as a major contributor to the current.24,25 The finding that pHo and Zn2+ also modulated IKV is consistent with a role for IKV in their effects on membrane potential. It is unlikely to be a major role though, because our previous studies showed that IKV (both the transient and sustained components) contributes little to the normal maintenance of resting potential.7 The lack of effect of halothane on IKV, although producing membrane hyperpolarization and facilitation of IKN, provides further evidence to link resting potential regulation to IKN and TASK-1 channels, rather than IKV. Previous studies showed that mRNA for TASK channels is expressed in the lung.21 We now extend these observations to show that TASK-1 mRNA and protein are expressed in PASMCs. Moreover, antibody staining showed TASK-1 expression at the surface membrane, compatible with a functional role in mediating membrane K+ currents.

The sensitivity of IKN to small changes in pHo means that extracellular acidification depolarizes PASMCs, thereby facilitating voltage-gated Ca2+ entry and contraction. Thus, modulation of IKN and membrane potential may contribute to acidosis-induced pulmonary vasoconstriction33 and the well known pulmonary vasodilator effect of alkalosis, which is inhibited by 10 mmol/L 4-aminopyridine and by manipulations that suppress the transmembrane K+ gradient and cause depolarization.34 Because IKN inhibition and membrane depolarization may contribute to the vasoconstrictor response of pulmonary arteries to hypoxia,6 pHo-dependent modulation of IKN may also explain the stimulatory effect of acidosis and inhibitory effect of alkalosis on hypoxic pulmonary vasoconstriction.35 The exquisite sensitivity of IKN to changes in pHo suggests that pHo-dependent modulation of IKN plays a functional role in physiological conditions, but it may become particularly important in pathological conditions where substantial changes in pHo can occur.36

The finding that acidosis inhibited the facilitation caused by halothane supports the hypothesis that halothane was acting on pH-sensitive TASK-1 channels. It is important to note, however, that the effects of halothane, Zn2+, and anandamide on IKN and membrane potential were not always as expected for modulation of TASK-1 channels. The failure of a small proportion of cells to respond to these agents suggests that the expression of TASK-1 channels may vary among PASMCs. Variable expression of K+ channels has been reported before and is thought to reflect phenotypic diversity among PASMCs.37,38 The inhibitory effect of halothane seen in some PASMCs seemed to obscure the facilitation at high concentrations and probably limited it at lower concentrations. This effect could be due to a separate action on additional channels that contribute to IKN. Halothane was recently found to inhibit an O2-sensitive background K+ current in glossopharyngeal neurons, which has a pharmacological profile compatible with THIK, another family of two-pore domain K+ channels.39 Like IKN, this current was insensitive to TEA and inhibited by millimolar quinidine, but it was only weakly modulated by pHo and not inhibited by 5 mmol/L 4-aminopyridine. It is therefore interesting that although acidosis inhibited IKN, it did not completely abolish it, and previous studies have shown that maximally effective concentrations of 4-aminopyridine only partially inhibit IKN.7 Thus several observations suggest that IKN may reflect the activity of more than a single population of K+ channels with differential sensitivity to pHo and pharmacological agents, and that the relative expression of these channels may vary among PASMCs. This is consistent with other cell types, where multiple K+ channels contribute toward the background K+ conductance that controls the resting potential.40


*    Acknowledgments
 
Acknowledgments

Funding for this study was provided by the Biotechnology and Biological Sciences Research Council and the British Heart Foundation.


*    Footnotes
 
Original received May 20, 2003; revision received September 10, 2003; accepted September 25, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Hara Y, Kitamura K, Kuriyama H. Actions of 4-aminopyridine on vascular smooth muscle tissues of the guinea-pig. Br J Pharmacol. 1980; 68: 99–106.[Medline] [Order article via Infotrieve]

2. Hasunuma K, Rodman DM, McMurtry IF. Effects of K+ channel blockers on vascular tone in the perfused rat lung. Am Rev Respir Dis. 1991; 144: 884–887.[Medline] [Order article via Infotrieve]

3. Post JM, Hume JR, Archer SL, Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol. 1992; 262: C882–C890.[Medline] [Order article via Infotrieve]

4. Clapp LH, Davey R, Gurney AM. ATP-sensitive K+ channels mediate vasodilation produced by lemakalim in rabbit pulmonary artery. Am J Physiol. 1993; 264: H1907–H1915.[Medline] [Order article via Infotrieve]

5. Wanstall JC. The pulmonary vasodilator properties of potassium channel opening drugs. Gen Pharmacol. 1996; 27: 599–605.[Medline] [Order article via Infotrieve]

6. Gurney AM, Osipenko ON, MacMillan D, Kempsill EJ. Potassium channels underlying the resting potential of pulmonary artery smooth muscle cells. Clin Exp Pharmacol Physiol. 2002; 29: 330–333.[CrossRef][Medline] [Order article via Infotrieve]

7. Evans AM, Osipenko ON, Gurney AM. Properties of a novel K+ current that is active at resting potential in rabbit pulmonary artery smooth muscle cells. J Physiol. 1996; 496: 407–420.[Abstract/Free Full Text]

8. Osipenko ON, Evans AM, Gurney AM. Regulation of the resting potential of rabbit pulmonary artery myocytes by a low threshold, O2-sensing potassium current. Br J Pharmacol. 1997; 120: 1461–1470.[CrossRef][Medline] [Order article via Infotrieve]

9. Millar JA, Barratt L, Southan AP, Page KM, Fyffe RE, Robertson B, Mathie A. A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons. Proc Natl Acad Sci U S A. 2000; 97: 3614–3618.[Abstract/Free Full Text]

10. Talley EM, Lei Q, Sirois JE, Bayliss DA. TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron. 2000; 25: 399–410.[CrossRef][Medline] [Order article via Infotrieve]

11. Washburn CP, Sirois JE, Talley EM, Guyenet PG, Bayliss DA. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. J Neurosci. 2002; 22: 1256–1265.[Abstract/Free Full Text]

12. Barbuti A, Ishii S, Shimizu T, Robinson RB, Feinmark SJ. Block of the background K+ channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Am J Physiol. 2002; 282: H2024–H2030.

13. Czirjak G, Fischer T, Spat A, Lesage F, Enyedi P. TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II. Mol Endocrinol. 2000; 14: 863–874.[Abstract/Free Full Text]

14. Harder DR, Madden JA, Dawson C. A membrane electrical mechanism for hypoxic vasoconstriction of small pulmonary arteries from cat. Chest. 1985; 88 (suppl 4): 233S–235S.[Abstract/Free Full Text]

15. Madden JA, Dawson CA, Harder DR. Hypoxia-induced activation in small isolated pulmonary arteries from the cat. J Appl Physiol. 1985; 59: 113–118.[Abstract/Free Full Text]

16. Archer SL, Huang JM, Reeve HL, Hampl V, Tolarova S, Michelakis E, Weir EK. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res. 1996; 78: 431–442.[Abstract/Free Full Text]

17. Lewis A, Hartness ME, Chapman CG, Fearon IM, Meadows HJ, Peers C, Kemp PJ. Recombinant hTASK1 is an O2-sensitive K+ channel. Biochem Biophys Res Commun. 2001; 285: 1290–1294.[CrossRef][Medline] [Order article via Infotrieve]

18. Buckler KJ, Williams BA, Honore E. An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells. J Physiol. 2000; 525: 135–142.[Abstract/Free Full Text]

19. Hartness ME, Lewis A, Searle GJ, O’Kelly I, Peers C, Kemp PJ. Combined antisense and pharmacological approaches implicate hTASK as an airway O2 sensing K+ channel. J Biol Chem. 2001; 276: 26499–26508.[Abstract/Free Full Text]

20. Plant LD, Kemp PJ, Peers C, Henderson Z, Pearson HA. Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. Stroke. 2002; 33: 2324–2328.[Abstract/Free Full Text]

21. Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol. 2000; 279: F793–F801.

22. Duprat F, Lesage F, Fink M, Reyes R, Heurteaux C, Lazdunski M. TASK, a human background K+ channel to sense external pH variations near physiological pH. EMBO J. 1997; 16: 5464–5471.[CrossRef][Medline] [Order article via Infotrieve]

23. Patel AJ, Honoré E, Lesage F, Fink M, Romey G, Lazdunski M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci. 1999; 2: 422–426.[CrossRef][Medline] [Order article via Infotrieve]

24. Maingret F, Patel AJ, Lazdunski M, Honoré E. The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1. EMBO J. 2001; 20: 47–54.[CrossRef][Medline] [Order article via Infotrieve]

25. Leonoudakis D, Gray AT, Winegar BD, Kindler CH, Harada M, Taylor DM, Chavez RA, Forsayeth JR, Yost CS. An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum. J Neurosci. 1998; 18: 868–877.[Abstract/Free Full Text]

26. Clapp LH, Gurney AM. Outward currents in rabbit pulmonary artery cells dissociated with a new technique. Exp Physiol. 1991; 76: 677–693.[Abstract]

27. Osipenko ON, Tate RJ, Gurney AM. Potential role for Kv3.1b channels as oxygen sensors. Circ Res. 2000; 86: 534–540.[Abstract/Free Full Text]

28. Bayliss DA, Talley EM, Sirois JE, Lei Q. TASK-1 is a highly modulated pH-sensitive ‘leak’ K+ channel expressed in brainstem respiratory neurons. Respir Physiol. 2001; 129: 159–174.[CrossRef][Medline] [Order article via Infotrieve]

29. Kim Y, Bang H, Kim D. TASK-3, a new member of the tandem pore K+ channel family. J Biol Chem. 2000; 275: 9340–9347.[Abstract/Free Full Text]

30. Post JM, Gelband CH, Hume JR. [Ca2+]i inhibition of K+ channels in canine pulmonary artery: novel mechanism for hypoxia-induced membrane depolarization. Circ Res. 1995; 77: 131–139.[Abstract/Free Full Text]

31. Clapp LH, Turner JL, Kozlowski RZ. Ca2+-activated Cl- currents in pulmonary arterial myocytes. Am J Physiol. 1996; 270: H1577–H1584.[Medline] [Order article via Infotrieve]

32. Patel AJ, Honoré E. Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci. 2001; 24: 339–346.[CrossRef][Medline] [Order article via Infotrieve]

33. Wray S. Smooth muscle intracellular pH: measurement, regulation, and function. Am J Physiol. 1988; 254: C213–C225.[Medline] [Order article via Infotrieve]

34. Gordon JB, Halla TR, Fike CD, Madden JA. Mediators of alkalosis-induced relaxation in pulmonary arteries from normoxic and chronically hypoxic piglets. Am J Physiol. 1999; 276: L155–L163.[Medline] [Order article via Infotrieve]

35. Brimioulle S, Lejeune P, Vachiery JL, Leeman M, Melot C, Naeije R. Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. Am J Physiol. 1990; 258: H347–H353.[Medline] [Order article via Infotrieve]

36. Aalkjaer C, Poston L. Effects of pH on vascular tension: which are the important mechanisms? J Vasc Res. 1996; 33: 347–359.[Medline] [Order article via Infotrieve]

37. Smirnov SV, Beck R, Tammaro P, Ishii T, Aaronson PI. Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries. J Physiol. 2002; 538: 867–878.[Abstract/Free Full Text]

38. Michelakis ED, Reeve HL, Huang JM, Tolarova S, Nelson DP, Weir EK, Archer SL. Potassium channel diversity in vascular smooth muscle cells. Can J Physiol Pharmacol. 1997; 75: 889–897.[CrossRef][Medline] [Order article via Infotrieve]

39. Campanucci VA, Fearon IM, Nurse CA. A novel O2-sensing mechanism in rat glossopharyngeal neurones mediated by a halothane-inhibitable background K+ conductance. J Physiol. 2003; 548: 731–743.[Abstract/Free Full Text]

40. Han J, Gnatenco C, Sladek CD, Kim D. Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus. J Physiol. 2003; 546: 625–639.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
E. E. Lloyd, S. P. Marrelli, K. Namiranian, and R. M. Bryan Jr.
Characterization of TWIK-2, a Two-Pore Domain K+ Channel, Cloned from the Rat Middle Cerebral Artery
Experimental Biology and Medicine, December 1, 2009; 234(12): 1493 - 1502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. Tang, Y. Li, C. Nagaraj, R. E. Morty, S. Gabor, E. Stacher, R. Voswinckel, N. Weissmann, K. Leithner, H. Olschewski, et al.
Endothelin-1 Inhibits Background Two-Pore Domain Channel TASK-1 in Primary Human Pulmonary Artery Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. J. Park, Y.-S. Chun, K. S. Park, S. J. Kim, S.-O. Choi, H.-L. Kim, and J.-W. Park
Identification of subdomains in NADPH oxidase-4 critical for the oxygen-dependent regulation of TASK-1 K+ channels
Am J Physiol Cell Physiol, October 1, 2009; 297(4): C855 - C864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. E. Lloyd, S. P. Marrelli, and R. M. Bryan Jr.
cGMP does not activate two-pore domain K+ channels in cerebrovascular smooth muscle
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1774 - H1780.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Joshi, V. Sedivy, D. Hodyc, J. Herget, and A. M. Gurney
KCNQ Modulators Reveal a Key Role for KCNQ Potassium Channels in Regulating the Tone of Rat Pulmonary Artery Smooth Muscle
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 368 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. L. Firth, K. H. Yuill, and S. V. Smirnov
Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L61 - L70.
[Abstract] [Full Text] [PDF]


Home page
Bioscience HorizonsHome page
S. D. Shah
Effects of modulators of TASK potassium channels on rat pulmonary artery tone
Bioscience Horizons, June 1, 2008; 1(2): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. J. Hwang, N. O'Kane, C. Singer, S. M. Ward, K. M. Sanders, and S. D. Koh
Block of inhibitory junction potentials and TREK-1 channels in murine colon by Ca2+ store-active drugs
J. Physiol., February 15, 2008; 586(4): 1169 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. M. Bryan Jr, B. K. Joseph, E. Lloyd, and N. J. Rusch
Starring TREK-1: The Next Generation of Vascular K+ Channels
Circ. Res., July 20, 2007; 101(2): 119 - 121.
[Full Text] [PDF]


Home page
Circ. Res.Home page
N. Blondeau, O. Petrault, S. Manta, V. Giordanengo, P. Gounon, R. Bordet, M. Lazdunski, and C. Heurteaux
Polyunsaturated Fatty Acids Are Cerebral Vasodilators via the TREK-1 Potassium Channel
Circ. Res., July 20, 2007; 101(2): 176 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kiyoshi, D. Yamazaki, S. Ohya, M. Kitsukawa, K. Muraki, S.-y. Saito, Y. Ohizumi, and Y. Imaizumi
Molecular and electrophysiological characteristics of K+ conductance sensitive to acidic pH in aortic smooth muscle cells of WKY and SHR
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2723 - H2734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Fantozzi, O. Platoshyn, A. H. Wong, S. Zhang, C. V. Remillard, M. R. Furtado, O. V. Petrauskene, and J. X.-J. Yuan
Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L993 - L1004.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. K. Weir and A. Olschewski
Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia
Cardiovasc Res, September 1, 2006; 71(4): 630 - 641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Wareing, X. Bai, F. Seghier, C. M. Turner, S. L. Greenwood, P. N. Baker, M. J. Taggart, and G. K. Fyfe
Expression and function of potassium channels in the human placental vasculature
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R437 - R446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Bryan Jr., J. You, S. C. Phillips, J. J. Andresen, E. E. Lloyd, P. A. Rogers, S. E. Dryer, and S. P. Marrelli
Evidence for two-pore domain potassium channels in rat cerebral arteries
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H770 - H780.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Fu, D. G. Beer, J. Behar, J. Wands, D. Lambeth, and W. Cao
cAMP-response Element-binding Protein Mediates Acid-induced NADPH Oxidase NOX5-S Expression in Barrett Esophageal Adenocarcinoma Cells
J. Biol. Chem., July 21, 2006; 281(29): 20368 - 20382.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. Musset, S. G. Meuth, G. X. Liu, C. Derst, S. Wegner, H.-C. Pape, T. Budde, R. Preisig-Muller, and J. Daut
Effects of divalent cations and spermine on the K+ channel TASK-3 and on the outward current in thalamic neurons
J. Physiol., May 1, 2006; 572(3): 639 - 657.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Olschewski, Y. Li, B. Tang, J. Hanze, B. Eul, R. M. Bohle, J. Wilhelm, R. E. Morty, M. E. Brau, E. K. Weir, et al.
Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells
Circ. Res., April 28, 2006; 98(8): 1072 - 1080.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. M. Sanders and S. Don Koh
Two-pore-domain potassium channels in smooth muscles: new components of myogenic regulation
J. Physiol., January 1, 2006; 570(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Yun Cho, E. A. Beckett, S. A. Baker, I. Han, K. J. Park, K. Monaghan, S. M. Ward, K. M. Sanders, and S. D. Koh
A pH-sensitive potassium conductance (TASK) and its function in the murine gastrointestinal tract
J. Physiol., May 15, 2005; 565(1): 243 - 259.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
X. Bai, G. J Bugg, S. L Greenwood, J. D Glazier, C. P Sibley, P. N Baker, M. J Taggart, and G. K Fyfe
Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium
Reproduction, April 1, 2005; 129(4): 525 - 530.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. D. Burmester, K.-D. Schluter, J. Daut, and P. J. Hanley
Enantioselective Actions of Bupivacaine and Ropivacaine on Coronary Vascular Resistance at Cardiotoxic Concentrations
Anesth. Analg., March 1, 2005; 100(3): 707 - 712.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Dubuis, M. Potier, R. Wang, and C. Vandier
Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels
Cardiovasc Res, February 15, 2005; 65(3): 751 - 761.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/10/957    most recent
01.RES.0000099883.68414.61v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurney, A.M.
Right arrow Articles by Kempsill, F.E.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurney, A.M.
Right arrow Articles by Kempsill, F.E.J.
Related Collections
Right arrow Functional genomics
Right arrow Ion channels/membrane transport
Right arrow Pulmonary circulation and disease